Seeking Alpha

Philip Morris International seeks FDA approval to keep marketing IQOS as reduced risk product

Philip Morris International (NYSE:PM) is urging the U.S. Food and Drug Administration to allow the company to continue marketing its heated tobacco products in the U.S. as a “modified risk tobacco ...
Arab Times

Philip Morris reaffirms commitment to smoke-free future in Kuwait

KUWAIT CITY, Jan 20: Philip Morris is reaffirming its commitment to Kuwait as a central market in its smoke-free strategy, ...
Nasdaq

ZYN and IQOS Scale Up: Is Philip Morris Leading the Industry Reset?

Philip Morris International Inc. PM is accelerating its shift from traditional tobacco to reduced-risk products, with strong momentum in its flagship offerings — IQOS and ZYN. In the first quarter of ...
Morningstar

Philip Morris International Urges U.S. Food and Drug Administration Advisory Committee to Recommend Continued Marketing of IQOS as Modified Risk Product

A pioneer in modified risk tobacco products, Philip Morris International is the only company to have received a modified risk marketing claim for an electronic nicotine device. FDA concludes “Evidence ...
Nasdaq

Can ZYN and IQOS Sustain Philip Morris' Smoke-Free Surge?

Philip Morris International’s PM smoke-free business is gaining scale, and the performance of its flagship products, IQOS and ZYN, is central to this trajectory. In the second quarter of 2025, the ...
Morningstar

Philip Morris Urges FDA to Back IQOS as Modified Risk Product

Philip Morris International is urging federal regulators to let it continue marketing its IQOS heated tobacco products in the U.S. as posing fewer health risks than traditional cigarettes. The tobacco ...